For example, in a non-small cell lung cancer model, CB2 activation with JWH-015 produced beneficial effects by inhibiting the acquisition of a malignant phenotype and reduced tumour growth (effects were blocked by SR2) [320]. The gene discussed is CNR2; the disease is neoplasm.